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in a C57BL/6 Mouse Model of Cuprizone-Induced Demyelination
Mehmet Önder Karayiğit¹ & Murat Yarım² 
ABSTRACT
Background: Demyelination refers to the degradation or loss of myelin sheath. In demyelination model studies, it has been 
reported that demyelination is regressed by giving steroid hormones such as estrogen and progesterone. However, there are 
not many studies investigating the synthesis of these two hormones by the brain during demyelination and remyelination. 
Neurosteroids are steroid hormones synthesized by the brain independently from peripheral tissues. In this study, it was 
aimed to have knowledge about the synthesis of these two hormones by the brain in experimentally formed demyelination 
process in brains of C57BL/6 mice and their role in the cellular response formed in the region.
Materials, Methods & Results: In the study, 36 C57BL/6 mice were used: 12 mice were fed normal diet for 12 weeks as 
control group (Group I); 12 of them were fed 0.2% cuprizone diet for 8 weeks (Group II) and 12 mice were fed normal diet 
for 4 weeks after feeding cuprizone diet for 8 weeks (Group III). At the end of the experiment, mice were perfused with 
4% paraformaldehyde and brain tissues were blocked in paraffin. 6 μm-thick section was taken from each block. Sections 
were stained histologically with LFB staining and immunohistochemically with MBP staining in order to determine the 
demyelination in sections. All sections were also immunohistochemically stained with GFAP to detect astrocytes, with NG2 
to detect young OPCs, with aromatase for estrogen synthesis and with 3βHSD antibodies for progesterone synthesis. At 
the end of the study, complete myelination was observed in group I, while severe demyelination was determined in group 
II as a result of blind evaluation of LFB and MBP staining by two pathologists. In group III, demyelination was found to 
be mild. In immunostaining with GFAP and NG2 antibodies, the number of GFAP and NG2 positive cells in Group II was 
found to be increased compared to the control group. The difference between these two groups was statistically significant 
(P < 0.01). In group III, the number of GFAP and NG2 positive cells were found to be increased compared to the control 
group; however, it was found to be lower than that in experimental group II (P < 0.01). In immunohistochemical stain-
ing with aromatase and 3βHSD antibody, there was no staining observed in the control groups. While an intense staining 
was observed in experimental group II, fewer glial staining was noticed in experimental group III when compared to the 
experimental group II. The difference between these two groups was found to be statistically significant (P ˂ 0.01).
Discussion: Aromatase is an enzyme that converts testosterone into estrogen. On the other hand, 3βHSD is an enzyme 
that converts pregnenolone to progesterone. Expression of aromatase from tissues refers to the synthesis of estrogen and 
expression of 3βHSD refers to progesterone synthesis. In previous demyelination studies carried out with cuprizone, 
it has been reported that demyelination is regressed by giving estrogen and progesterone during demyelination. In the 
presented study, we observed that enzyme levels that catalyze the synthesis of estrogen and progesterone increased dur-
ing demyelination. In the study, it was determined that estrogen and progesterone levels were increased in the region by 
enzymes released from the glial cells of the brain as a response to damage formed during demyelination. Interestingly, 
during the period in which cuprizone was excluded from the diet, it was observed that remyelination began to be formed 
again and that enzyme levels synthesizing these hormones started to decrease. These results suggested that estrogen and 
progesterone may be synthesized in the brain after a damage and may contribute to remyelination by initiating a number 
of cell to cell signaling steps.
Keywords: demyelination, cuprizone, aromatase, 3βHSD, remyelination.
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INTRODUCTION
Demyelination can occur because of ischemic, 
infectious and toxic causes. In diseases progressing 
with demyelination characterized by the loss of oligo-
dendrocytes, demyelination is thought to be associated 
with oxidative stress, mitochondrial damage and mi-
croglial activation [6,35]. This can activate astrocytes 
which can be both beneficial and harmful to the disease 
process [4,5,18,33,34,36].
When cuprizone was added to the diet of young 
male mice, it has been seen that demyelination was 
formed in central nervous system (CNS) and changes 
were determined in cellular, molecular, biochemical 
and morphological parameters around the lesions [22]. 
Following the damage occurred in CNS, some bioactive 
molecules with local protective effects are expressed 
from neurons and activated glial cells [14,17]. Some of 
these are neurosteroid hormones synthesized from the 
brain independently from the gonads and adrenal glands. 
Aromatase is an enzyme that catalyzes the 
synthesis of esrogen from the brain [1,9,32]. 3Beta 
hydroxysteroid dehydrogenase (3βHSD) is the enzyme 
that converts pregnenolone to progesterone. Expression 
of these two enzymes in the brain indicates the estro-
gen and progesterone synthesis in the brain [7]. When 
both estrogen and progesterone are given externally, 
oligodendroglial and neuronal death is prevented and 
myelin sheath synthesis is accelerated and the demy-
elination is regressed [8,12,26,29,30]. 
With this study, it was aimed to have informa-
tion about the role of estrogen and progesterone in the 
cellular response occurred in demyelination process 
by investigating the expression of neuro steroidogenic 
enzymes such as aromatase and 3βHSD from glial cells 
after the brain damage.
MATERIALS & METHODS
Animals
Three-month-old 36 male C57BL/6 mice with 
an average weight of 25 ± 5 g were used in the study. 
12 of mice were used as a control group by feeding 
standard mouse diet for 12 weeks (Group I). 12 mice 
were fed 0.2% cuprizone diet for 8 weeks (Group II) 
and the rest 12 mice were fed 0.2% cuprizone diet for 
8 weeks followed by normal diet for 4 weeks (Group 
III). Ad libitum access to drinking water was provided 
to all mice. 
At the end of the study, necropsy was con-
ducted to all mice following the cardiac perfusion with 
4% paraformaldehyde under 3 mg/kg ketamine HCl 
anesthesia. After cardiac perfusion, animals’ brains 
were removed and the sections were trimmed passing 
through the corpus callosum (CC) region. Trimmed 
brain samples were fixed in 4% paraformaldehyde solu-
tion for 24 h at +4°C, then washed under running water 
for one day and blocked in paraffin by treating with 
alcohol-xylol. Subsequently, 6 μm-thick sections were 
taken using the Rotary microtome (Leica, RM 2125)1.
 Luxol-Fast Blue (LFB) staining was performed 
histochemically to determine demyelination and remy-
elination in all tissue sections. Immunohistochemical 
(IHC) staining was performed on the tissues using 
avidin-biotin immunoperoxidase complex method. All 
tissue sections were deparaffinized in xylene and then 
rehydrated in graded alcohols. Then, antigen retrieval 
was performed for 20 min at 600 Watt and tissue sec-
tions were left to cool for 20 min. For endogenous 
peroxidase activity, they were kept in a methanol-3% 
hydrogen peroxide solution for 15 min. Sections were 
washed 3 times in phosphate buffer saline (PBS) for 
5 min each. All sections were treated with block solu-
tion for 10 min and myelin basic protein (MBP) [Anti 
MBP antibody, ab7349]2, glial fibrillary acidic protein 
(GFAP) [Anti GFAP antibody, ab7779]2, 3βHSD [Anti 
3βHSD ab65156]2, neural glial antigen 2 [Anti NG2 
antibody ab81104]2 and aromatase [Anti-P450arom 
antibody AP00001PU-N]3 antibodies were dropped 
on sections without washing and sections were incu-
bated for 1 h at room temperature. Following washing, 
biotin-labeled secondary antibody was dropped on 
sections and sections were incubated for 30 min and 
then washed with PBS 3 times for 5 min. Then, they 
were incubated with streptavidin-peroxidase [Zymed, 
Histostain Plus Kit]4 enzyme for 30 min. At the end 
of this period, the tissues were again washed 3 times 
with PBS for 5 min. 
Finally, controlled staining was applied to 
sections with 3-amino-9-ethylcarbazole chromogen4 
under the microscope for 10 min. Counterstaining was 
performed using Gill’s hematoxylin. Sections were 
closed with water-based adhesive and examined under 
light microscope [Nikon, YS 100]5.
Assessment of demyelination
Histochemically LFB and immunohistochemi-
cally MBP-stained sections were blindly scored from 0 
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to 3 by two pathologists. In the control group fed with 
normal diet, the amount of myelin was expressed as 3, 
the amount of mild demyelination as 2, the amount of 
severe demyelination as 1, and the amount complete 
demyelination as 0 [23].
Cell counting method
Sections taken passing through the CC region 
according to the brain atlas prepared by Harward 
University for C57BL/6 mice were immunohisto-
chemically stained with GFAP, NG2, Aromatase and 
3βHSD antibodies and the whole mentioned region 
was photographed with Nikon DS Camera10. For each 
antibody, each cell of which cytoplasm was positively 
stained was counted separately, and the results of all 
staining methods were evaluated statistically (Table 1).
Statistical analysis
In the study, differences between the groups 
were analyzed using one-way analysis of variance 
technique according to the organs. Intergroup differ-
ences were investigated using DUNCAN multiple 
comparison test. In addition, introductory statistics 
for the groups were listed in Table 1. The results 
were obtained using SAS [2009] statistical package 
program.
Table 1. Intergroup differences investigated using DUNCAN multiple comparison test.
Group GFAP P450arom 3βHSD NG2
I (Control) 23.00 ± 1.86c 0.00 ± 0.00c 0.00 ± 0.00c 10.25 ± 0.75c
II 166.16 ± 10.37a 33.91 ± 2.06a 25.33 ± 2.00a 42.50 ± 17.0a
III 84.75 ± 4.42b 13.41 ± 1.47b 9.66 ± 1.32b 18.50 ± 1.89b
a, b, c the difference between group averages is statistically significant (P < 0.01). Average values obtained from median kind.
RESULTS
In the study, the amount of myelin obtained 
from the staining with LFB (Figure 1) and MBP 
(Figure 2) was evaluated by two pathologists. In the 
control group, group I, a complete myelination was 
detected while a severe demyelination was detected in 
group II, whereas in group III in which cuprizone was 
excluded from the diet, remyelination was formed and 
demyelination regressed to mild level.
In addition, in IHC staining performed with 
GFAP (Figure 3) to determine astrocytes and with NG2 
(Figure 4) to determine young oligodendrocyte precursor 
(OPC) cells, low number of cells were positive stained 
in Group I which was the control group, whereas the 
number of positive stained cells were found to increase 
significantly in group II in which severe demyelination 
was detected. In the 3rd group in which demyelination 
regressed after exclusion of cuprizone from the ration 
and remyelination was formed, the number of positive 
stained cells was found to be higher than that in control 
group but less than that in the group II in which demy-
elination was formed (P < 0.01).
In IHC staining with aromatase (Figure 5) and 
3βHSD (Figure 6) antibodies, there was no positive 
staining detected in glial cells in control group. In the 
group II in which demyelination occurred, positive 
stained glial cells were observed whereas, in the group 
III in which remyelination was formed, the number of 
positive stained cells was found to decrease signifi-
cantly compared to group II (P < 0.01).
Figure 1. a- Complete myelination in CC in control group (arrows). [LFB, Bar= 100 μm]. b- Severe demyelination in CC in 
group II (arrows). [LFB, Bar= 100 μm]. c- Mild demyelination in CC in group III (arrows). [LFB, Bar= 100 μm].
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Figure 2. a- Severe expression for MBP antibody in CC in control group (arrows). [IHC, Bar= 100 μm]. b- Mild expression 
for MBP antibody in CC in group II (arrows). [IHC, Bar= 100 μm]. c- Moderate expression for MBP antibody in group III 
in CC (arrows). [IHC, Bar= 100 μm].
Figure 3. a- Mild expression for GFAP antibody in CC in control group (arrows). [IHC, Bar= 25 μm]. b- Severe expression for 
GFAP antibody in CC in group II (arrow). [IHC, Bar= 25 μm]. c- Moderate expression for GFAP antibody in CC in group III 
(arrow). [IHC, Bar= 25 μm].
Figure 4. a- Mild expression for NG2 antibody in CC in control group (arrow). [IHC, Bar= 25 μm]. b- Severe expression for 
NG2 antibody in CC in group II (arrow). [IHC, Bar= 25 μm]. c- Moderate expression for NG2 antibody in CC in group III 
(arrow). [IHC, Bar= 25 μm].
Figure 5. a- Negative expression for aromatase antibody in CC in control group. [IHC, Bar= 25 μm]. b- Severe expression 
for aromatase antibody in CC in group II (arrows). [IHC, Bar= 25 μm]. c- Mild expression for aromatase antibody in CC in 
group III (arrows). [IHC, Bar= 25 μm].
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Figure 6. a- Negative expression for 3βHSD antibody in CC in control group. [IHC, Bar= 25 μm]. b- Severe expression for 
3βHSD antibody in CC in group II (arrows). [IHC, Bar= 25 μm]. c- Mild expression for 3βHSD antibody in CC in group III 
(arrow). [IHC, Bar= 25 μm].
DISCUSSION
Aromatase is the enzyme that catalyzes the 
synthesis of estrogen [1] The expression of aromatase 
in the brain is very low under normal conditions and 
is limited to neurons [13,19,20]. However, it has been 
found that the expression of aromatase from neurons 
increases, thus the level of local estrogen increases 
after experimentally formed neuronal damage [8,9,24]. 
The investigations conducted have suggested that the 
increase in estrogen level associated with neuronal 
damage may be a protective feature specific to brains 
of vertebrates and may be an important component in 
the initiation of a neuronal response to damage [8,9,24]. 
Progesterone has been reported to play an 
important role in regeneration of neurons and myelin 
formation [25,37]. 3βHSD catalyzes the progesterone 
synthesis and expression of 3βHSD from tissues indi-
cates progesterone synthesis in the region [11].
 In the study conducted by Taylor et al. [31] 
C57BL/6 mice were fed cuprizone diet and demy-
elination was formed, while estrogen was given as a 
subcutaneous implant to another group at the same 
time. They have found mature oligodendrocyte loss, 
microglial accumulation, and decreased IGF-1 and 
TNFα release in the group in which implant was ap-
plied compared to the group in which implant was not 
applied. Besides prevention of apoptosis of oligoden-
drocytes by giving estrogen externally, they have found 
that IGF-1 release can also be reduced suppressing 
microglia and astrocyte activation, thus demyelination 
can partially be prevented by the reduction of harmful 
substances such as TNFα released from these cells [31].
Another study has reported that while forming 
demyelination with cuprizone in C57BL/6 mice, giv-
ing progesterone with estrogen externally at the same 
time was found to be more beneficial than the effect 
of estrogen alone on demyelination [23]. Contrary to 
Taylor et al. [31], Peter et al. [23] have emphasized 
that co-administration of estrogen and progesterone 
increases the number of astrocytes and demyelination 
can be greatly inhibited by stimulation of IGF-1 release 
from glial cells. These two studies conducted are the 
closest ones to the presented study in terms of animal 
used and demyelination model. However, unlike these 
two studies, estrogen and progesterone were not exter-
nally administered during demyelination process but it 
is thought that aromatase and 3βHSD enzymes were 
expressed from the astrocytes in the region, and ac-
cordingly, progesterone and estrogen were synthesized 
in the damaged region. There are studies showing that 
the level of aromatase expressed from the neurons in 
the region increases after neuronal damage [8,9,24]. 
However, there is one study in which aromatase is 
expressed from glial cells after demyelination [34]. 
Aromatase enzyme expression from glial cells 
increased in demyelination formed during distemper 
[34]. In the study conducted by Yarim et al. [34] they 
have found that aromatase expression was very low 
from astrocytes in the cerebellum of dogs, whereas 
aromatase expression of astrocytes in demyelination 
region in cerebellum of animals with distemper in-
creased. In presented study, aromatase expression 
was observed in the group in which demyelination 
occurred, while the aromatase expression from glial 
cells was not observed in the CC region of brain of 
mice in control group. It is believed that the difference 
observed in control group animals in two mentioned 
studies are likely to vary according to the animal spe-
cies or the different regions of the CNS. 
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Although there is no study showing that proges-
terone is synthesized in the brain during demyelination, 
there are studies reporting that the externally given pro-
gesterone regresses demyelination [23,25,34,37]. In the 
study, it was found that young OPC and astrocytes in 
the region proliferated besides estrogen and progester-
one synthesis during demyelination [23]. Although the 
pathogenesis was not clear, it is thought that the level 
of these two neurosteroid hormones may increase in 
order to protect the brain during demyelination and that 
cellular proliferation may initiate the signaling stages 
for remyelination. Because in the study, when the cu-
prizone was excluded from the diet, remyelination was 
formed in the region again and the OPC increase, glial 
activation and hormone expressions began to decrease 
significantly [8,9,13,19,20,24].
These results suggest that damage in the brain 
can be repaired at a certain level without any treatment 
or stimulant applied externally when the effect causing 
damage in the brain is removed. These findings are 
thought to be important in the brain, which is vital, 
and does not have regeneration feature. However, this 
mechanism is complex and full of assumptions. It is 
a strong assumption that estrogen and progesterone 
synthesized in response to the damage in the area was 
the effect initiating remyelination in the study.
 It has been reported that CNS cells, especially 
astrocytes, are important in the MS-related demyelin-
ation and remyelination mechanism and demyelination 
can progress as a result of the increase of inflammatory 
cytokines released from astrocytes with the proliferation 
of these cells, and apoptosis of oligodendrocytes because 
of cuprizone [28]. On the other hand, it has been reported 
that estrogen stimulates the release of various growth 
factors from reactivated astrocytes when given externally, 
and that these growth factors accelerate remyelination by 
inhibiting oligodendrocyte apoptosis and providing OPC 
migration to the region with lesion [8,15,31]. Estrogen can 
also stimulate progesterone synthesis from astrocytes by 
stimulating them [21,27]. It is not known which mecha-
nism stimulated the synthesis of aromatase from glial 
cells in this presented study, however, it is thought that 
in some way there may be a compensation mechanism in 
response to demyelination. Aromatase expression from 
glial cells may have initiated local estrogen production 
in CC region of brain. Estrogen synthesis can trigger 
local synthesis of progesterone from astroglial cells by 
stimulating their proliferation just as in studies in which 
estrogen was given externally [3,11,16,21,27]. 
The results of this study support the hypothesis 
suggesting that progesterone can regress demyelination 
by stimulating OPC migration to the region of demy-
elination and inhibiting oligodendrocyte apoptosis 
[9,15,23,28,31]. Because, in the study, OPC migration 
was detected with the proliferation of astrocytes in the 
region of demyelination. 
As a result, estrogen and progesterone synthe-
sized with the activation of the protective mechanism 
during demyelination in the brain may not provide a 
fast recovery as the estrogen and progesterone given 
externally. However, knowing the existence of such 
mechanism can be a step for future studies, and perhaps 
with more extensive studies, results that can make this 
mechanism more active in humans and animals before 
the damage reaches a critical level during diseases 
characterized with demyelination, can be obtained.
CONCLUSIONS
Increased expression levels of steroidogenic 
enzymes such as aromatase and 3βHSD in the glial 
cells following demyelination could increase estro-
gen and progesterone and this contribute significantly 
through regression of the demyelination and progres-
sion of the remyelination.
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